Microbix Biosystems Inc. (MBX.TO) TSX

Currency In CAD

AD

Valuation

Market Cap36.88M
Enterprise Value31.53M
P/E Ratio-8.78
PEG Ratio0.07
Price/Sales Ratio2.77
Price/Book Ratio1.72
Enterprise/Revenue2.74
Enterprise/EBITDA-18.34

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.32
Operating Margin-0.28
AD

Management Effectiveness

Return On Assets-0.14
Return On Equity-0.19

Income Statement

Revenue18.59M
Revenue/Share0.11
Gross Profit9.85M
EBITDA428,231
Net Income-2.25M
Diluted EPS-0.02

Balance Sheet

Total Cash7.16M
Total Cash/Share0.05
Total Debt6.72M
Total Debt/Equity0.28
Current Ratio6.89
Book Value Per Share0.18

Price History

52-Week Change19.23
52-Week High0.33
52-Week Low0.21
Moving Average 50 Days0.3
Moving Average 200 Days0.27

Statistics

Average Volume26,864
Shares Outstanding137.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD